greeksoup/ stock research

CME Group (CME) FY2021 results: revenue $4.7 billion, down 4.0% on the year

CME Group Inc. (CME) reported revenue of $4.7 billion for fiscal 2021, the year ended 31 December 2021, down 4.0% on the year before. Net income was $2.6 billion, up 25.2%, and diluted earnings per share $7.29. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2022.

Revenue
$4.7 billion
-4.0% on the year
FY2014FY2021
Operating margin
56.4%
54.0% a year earlier
FY2014FY2021
Net income
$2.6 billion
+25.2% on the year
FY2014FY2021
Diluted EPS
$7.29
+24.2% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue4,6904,8844,868-4.0%
Operating income2,6452,6372,588+0.3%
Operating margin56.4%54.0%53.2%
Pre-tax income3,3742,7222,690+23.9%
Income tax737616574+19.7%
Effective tax rate21.8%22.6%21.3%
Net income2,6362,1052,116+25.2%
Net margin56.2%43.1%43.5%
Diluted EPS$7.29$5.87$5.91+24.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow2,4022,7162,673-11.5%
Capital expenditure127198246-35.6%
Free cash flow2,2752,5182,427-9.6%
Free cash flow margin48.5%51.6%49.9%
Cash from investing58.4-176-153
Cash from financing69,90947,247-2,341+48.0%
Depreciation and amortisation148153159-3.5%
Share-based compensation75.296.073.1-21.7%
Dividends paid2,1892,1101,696+3.8%
Dividend per share$6.85$5.90$5.50+16.1%
Diluted shares, weighted359m359m358m+0.1%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity27,39926,32026,129+4.1%
Non-controlling interest0.031.630.4
Short-term borrowingsn/a0.00.0
Debt3,4453,4443,743+0.0%
Operating lease liabilities449492515-8.7%
Finance lease liabilities75.983.891.5-9.4%
Other liabilities165,41194,28844,706+75.4%
Total liabilities and equity196,780124,66075,215+57.9%
Fixed assets505579544-12.8%
Goodwill10,52810,79910,742-2.5%
Intangible assets3,5324,8655,118-27.4%
Investments11510183.2+14.0%
Trading assets98.682.666.1+19.4%
Cash and equivalents2,8351,6331,551+73.6%
Receivables434461492-5.8%
Other assets178,732106,13856,619+68.4%
Total assets196,780124,66075,215+57.9%

10-K for the year ended 31 December 2021, filed 25 February 2022: the filing.